CGAS and metabolic dysfunction-associated steatotic liver disease: In the context of chronic liver diseases, including MASLD and alcoholic hepatitis, persistent heightened activity of the cGAS-STING cascade can exacerbate hepatic inflammation, potentially accelerating disease advancement and even fostering HCC development.